GenEditBio
PrivateLast Round
Strategic
Sep 30, 2024
Total Funding Raised
$10.54M
Company Overview
GenEditBio is a biotechnology company that develops in vivo genome editing-based therapeutic solutions for genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenEditBio Comps
Public and private peers based on sector, stage, and business model.
GenEditBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 30, 2024 | ||||
| Early Funding | Apr 4, 2024 | ||||
| Grant | Mar 1, 2024 | ||||
| Early Funding | May 25, 2022 |
GenEditBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FountainVest Partners | Early Funding |
| HKSTP Ventures | Early Funding |
| Qiming Venture Partners | Grant, Early Funding |
| Innovation and Technology Venture Fund | Grant, Early Funding |
| Gobi Partners GBA | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2025
Grew 17% QoQ from 18 to 21 employees.
- Sep 30, 2024
Led by Gobi Partners GBA.
GenEditBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GenEditBio's valuation, stock price, and market status.